Literature DB >> 32494153

Long Non-Coding RNA NEAT1 Serves as Sponge for miR-365a-3p to Promote Gastric Cancer Progression via Regulating ABCC4.

Ming Gao1, Liying Liu2, Dianbao Zhang3, Yudan Yang1, Zhiwei Chang1.   

Abstract

INTRODUCTION: Long non-coding RNA (lncRNA) was reported to be a crucial regulator in cancer. In this work, our purpose is to explore the biological roles of nuclear paraspeckle assembly transcript 1 (NEAT1) in gastric cancer (GC).
METHODS: Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to detect NEAT1 expression in GC cells and normal cells. GC cell behaviors after NEAT1 overexpression or downregulation were analyzed by Cell Counting Kit-8 assay, colony formation assay, wound-healing assay, and flow cytometry assay. Bioinformatic tools were used to analyze the significance of NEAT1 in GC. The involvement of microRNA-365a-3p (miR-365a-3p) and ATP-binding cassette subfamily C member 4 (ABCC4) in the biological roles of NEAT1 in GC progression was validated by luciferase activity reporter assay and rescue experiments.
RESULTS: We found NEAT1 increased expression in both GC tissues and cells and correlated with poorer overall survival of cancer patients. We found NEAT1 overexpression promotes, while its knockdown inhibits GC cell proliferation, colony formation, invasion, and cell cycle progression in vitro. Mechanism analyses showed that NEAT1 serves as a ceRNA to upregulate ABCC4 expression via sponging miR-365a-3p.
CONCLUSION: In this study, we revealed a NEAT1/miR-365a-3p/ABCC4 triplet in GC progression, which may provide novel targeted therapy markers for GC.
© 2020 Gao et al.

Entities:  

Keywords:  ABCC4; NEAT1; gastric cancer; long non-coding RNA; miR-365a-3p

Year:  2020        PMID: 32494153      PMCID: PMC7227816          DOI: 10.2147/OTT.S245557

Source DB:  PubMed          Journal:  Onco Targets Ther        ISSN: 1178-6930            Impact factor:   4.147


Introduction

More than half of gastric cancer (GC) cases are diagnosed in East Asia.1 Most of GC patients were diagnosed at late stages with malignant metastasis and thus results in poorer overall survival of cancer patients.2 Hence, identifying novel therapeutic targets for GC is needed to improve the  survival quality of GC patients.3 The in-depth understanding of RNA biology demonstrated RNA is not only a bridge between DNA and protein but also played crucial roles in multiplies cellular processes.4 Long non-coding RNA (lncRNA) is a type RNA with limited coding capacity and at the length of over 200 nucleotides.5 The importance of lncRNAs in regulating cancer progression has been appreciated in recent years.6 Nuclear paraspeckle assembly transcript 1 (NEAT1) is a newly discovered lncRNA that is an essential component of nuclear paraspeckles.7 Moreover, NEAT1 was reported could function as oncogenic lncRNA in cancers. Shan et al showed NEAT1 was elevated expression in bladder cancer, and its overexpression was found to promote bladder cancer progression in vitro via regulating microRNA-410 and high-mobility group box 1.8 In prostate cancer, NEAT1 was found highly expressed in docetaxel-resistant samples, and its oncogenic role was exerted through sponging miR-34a-5p and miR-204-5p.9 Moreover, NEAT1 was also found elevated expression in GC, and its overexpression was found to promote cancer peogewaaion via upregulating miR-17 and activating PI3K/AKT and GSK3β pathways.10 lncRNA was found could exert its biological roles through competitively binding with miRNA.11 miR-365a-3p was reported to have a tumor-suppressive role in pancreatic cancer but an oncogenic role in laryngeal squamous cell carcinoma.12,13 For instance, miR-365a-3p was found to decrease expression in pancreatic cancer tissues and regulates c-Rel to inhibit cancer progression.12 On the contrary, miR-365a-3p was found elevated expression in laryngeal squamous cell carcinoma, and the knockdown of miR-365a-3p could suppress cell growth, metastasis through regulating PI3K/AKT signaling pathway.13 These results implied the importance of miR-365-3p in regulating cancer progression. However, the connection of NEAT1 and miR-365a-3p was not explored previously. In this work, we aimed to explore the biological roles of NEAT1 and its associated mechanisms in GC, with the hope to develop novel therapeutic targets for GC treatment.

Materials and Methods

Cell Culture

GC cells MGC-803, HGC-27, and BGC-823, and normal gastric cell GES-1 were purchased from Cell Bank of Chinese Academy of Sciences (Shanghai, China). These cells were incubated in RPMI 1640 in supplement with 10% fetal bovine serum (Thermo Fisher Scientific, Waltham, MA, USA) at a 37°C moist incubator contains 5% CO2.

Cell Transfection

miR-365a-3p mimic and negative control (NC-miR) were purchased from GenePharm (Shanghai, China). NEAT1 sequence was cloned into pcDNA3.1 to generate pNEAT1 by GenScript (Nanjing, Jiangsu, China). Small interfering RNA against NEAT1 (si-NEAT1), ABCC4 (si-ABCC4) and negative control (NC-siR) were purchased from GenePharm. Cell transfection was conducted using Lipofectamine 2000 (Invitrogen, Thermo Fisher Scientific). After 48 h of transfection, cells were collected for further analyses.

Reverse Transcription-Quantitative Polymerase Chain Reaction (RT-qPCR)

RNA was isolated with Trizol reagent and then reverse-transcribed into first-strand complementary DNA using M-MLV Reverse Transcriptase kit (Invitrogen) according to the provided protocols. RT-qPCR was conducted using SYBR Green (Takara, Dalian, Liaoning, China) at ABI 7500 system (Applied Biosystems, Foster City, CA, USA). Primers used were as follows: miR-365a-3p forward, 5′-TAATGCCCCTAAAAATCCTTAT-3′ and reverse, 5′-CAGTGCGTGTCGTGGAGT-3′; U6 snRNA forward, 5′-CTCGCTTCGGCAGCACA-3′ and reverse, 5′-AACGCTTCACGAATTTGCGT-3′, NEAT1 forward, 5′-TGGCTAGCTCAGGGCTTCAG-3′ and reverse, 5′- TCTCCTTGCCAAGCTTCCTTC-3′; ABCC4 forward, 5′- GGCAGTGACGCTGTATGG-3′ and reverse, 5′-CGCCAGGTCTGACAGTAAAG-3′; GAPDH forward, 5′-CTGGGCTACACTGAGCACCAG-3′ and reverse, 5′-CCAGCGTCAAAGGTGGAG-3′. Relative gene expression level was calculated by 2−ΔΔCt method with GAPDH or U6 snRNA as internal controls.

Cell Proliferation Assay

Cell Counting Kit-8 (CCK-8, Beyotime, Haimen, Jiangsu) was used to analyze cell proliferation. Cells were seeded in 96-well plate at the density of 3 × 103 and incubated for indicated time points. Then, CCK-8 reagent was added to each well and further incubated for 2 h. Absorbance of each well was measured at 450 nm using a microplate reader.

Cell Cycle Analysis

Cells were collected and then digested by trypsin and fixed by 70% cold ethanol. The treated cells were stained by PI (Beyotime) in the supplement of RNase A for 30 min. Cell cycle distribution was analyzed at FACSCalibur system (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) equipped with ModFit software (Verity Software House, Topsham, ME, USA).

Colony Formation Assay

A 5 × 103 cells were seeded in 6-well plates and cultured for 2 weeks at the above-described conditions. Then, cells were fixed by methanol and dyed by crystal violet. Finally, colony numbers were counted using a microscope.

Transwell Invasion Assay

Transwell chamber with 8 μm pore size was used to detect cell invasion ability. A 5 × 104 cells in serum-free medium were seeded in the upper chamber. Moreover, medium in supplement with FBS was filled into the lower chamber. After 48 h incubation, non-invasive cells were removed, while invaded cells were fixed by paraformaldehyde and stained with crystal violet. Invasive cell numbers were counted under a microscope.

Dual-Luciferase Reporter Assay

Bioinformatic analysis tools were utilized to predict the miRNA target of NEAT1 and we found miR-365a-3p was a putative target. In addition, the target of miR-365a-3p was predicted by bioinformatic tool and showed ABCC4 was a possible target. The wild-type sequence of NEAT1 and ABCC4 was cloned into pmirGLO (Promega, Madison, WI, USA) and designated as NEAT1-wt or ABCC4-wt. In addition, the sequences with mutations in binding regions were generated using site-direct mutagenesis kit (Takara) and named as NEAT1-mt or ABCC4-mt. Cells were co-transfected with luciferase vectors and miRNAs using Lipofectamine 2000. Relative luciferase activity was measured using Dual-Luciferase Reporter assay system (Promega) after 48 h transfection using Renilla luciferase activity as an internal control.

Detection of NEAT1, miR-365a-3p, and ABCC4 Expression in GC Tissues and Normal Tissues

ENCORI website () was used to detect NEAT1, miR-365a-3p, and ABCC4 expression levels in GC tissues and normal tissues.

Detection of the Significance of NEAT1 and ABCC4 Expression in GC

Kaplan–Meier curve website () was used to detect the clinical significance of NEAT1 and ABCC4 on GC patients.

Statistical Analysis

Data collected from three independent experiments were analyzed at GraphPad Prism 6.0 and presented as mean ± standard deviation. Two-tailed Student’s t-test and one-way analysis of variance were used to measure significant differences in groups. P < 0.05 was believed to indicate statistically significant.

Results

NEAT1 Was Upregulated Expression in GC and Correlated with Poor Overall Survival

RT-qPCR analysis showed NEAT1 expression in GC cells was significantly higher than that in normal cells (Figure 1A). Moreover, we found that NEAT1 also upregulated expression in GC tissues compared with normal tissues using ENCORI (Figure 1B). Importantly, we showed high NEAT1 expression was an indicator of poorer overall survival of GC patients (Figure 1C). These results implied the importance of NEAT1 in GC progression.
Figure 1

NEAT1 was upregulated in GC and correlated with poorer overall survival.

Notes: (A) NEAT1 expression in GC cells and normal cells. (B) NEAT1 expression in GC tissues and normal tissues. (C) High NEAT1 expression was a predictor for poorer overall survival of cancer patients. ***P<0.001.

Abbreviations: NEAT1, nuclear paraspeckle assembly transcript 1; GC, gastric cancer.

NEAT1 was upregulated in GC and correlated with poorer overall survival. Notes: (A) NEAT1 expression in GC cells and normal cells. (B) NEAT1 expression in GC tissues and normal tissues. (C) High NEAT1 expression was a predictor for poorer overall survival of cancer patients. ***P<0.001. Abbreviations: NEAT1, nuclear paraspeckle assembly transcript 1; GC, gastric cancer.

Knockdown and Overexpress Efficiency of NEAT1 in GC Cells

To explore the biological roles of NEAT1 in GC progression, we established NEAT1 knockdown and overexpression cells. RT-qPCR showed the introduction of si-NEAT1 significantly decreased NEAT1 expression in GC cells compared with NC-siR (Figure 2A). Moreover, the introduction of pNEAT1 increased the levels of NEAT1 in GC cells (Figure 2B).
Figure 2

Influences of NEAT1 expression on GC cell invasion.

Notes: (A) NEAT1 expression in GC cells with si-NEAT1 and NC-siR transfection. (B) NEAT1 expression in GC cells with pNEAT1 and pcNDA3.1 transfection. (C) Cell invasion ability in GC cells with si-NEAT1 and NC-siR transfection. (D) Cell invasion ability in GC cells with pNEAT1 and pcNDA3.1 transfection. ***P<0.001.

Abbreviations: NEAT1, nuclear paraspeckle assembly transcript 1; GC, gastric cancer; si-NEAT1, small interfering RNA against NEAT1; NC-siR, negative control small interfering RNA.

Influences of NEAT1 expression on GC cell invasion. Notes: (A) NEAT1 expression in GC cells with si-NEAT1 and NC-siR transfection. (B) NEAT1 expression in GC cells with pNEAT1 and pcNDA3.1 transfection. (C) Cell invasion ability in GC cells with si-NEAT1 and NC-siR transfection. (D) Cell invasion ability in GC cells with pNEAT1 and pcNDA3.1 transfection. ***P<0.001. Abbreviations: NEAT1, nuclear paraspeckle assembly transcript 1; GC, gastric cancer; si-NEAT1, small interfering RNA against NEAT1; NC-siR, negative control small interfering RNA.

Influence of NEAT1 on GC Cell Invasion

Transwell invasion assay was performed to detect the effects of NEAT1 on GC cell invasion. As shown in Figure 2C and D, we found NEAT1 knockdown could inhibit, while NEAT1 overexpress could stimulate GC cell invasion.

Influence of NEAT1 on GC Cell Growth

Then, the effects of NEAT1 on GC cell growth were detected in vitro. CCK-8 assay showed cell proliferation rate was higher in pNEAT1 group than that in pcDNA3.1 group, and lower in si-NEAT1 group than in NC-siR group (Figure 3A and B). Flow cytometry showed the percentage in G0/G1 phase in pNEAT1 group was lower than that in pcDNA3.1 group, while the introduction of si-NEAT1 caused cell cycle arrest (Figure 3C and D). Colony formation assay indicated colony numbers were higher in pNEAT1 group than that in pcDNA3.1 group (Figure 3E). Moreover, compared with the NC-siR group, colony numbers in si-NEAT1 group were significantly decreased (Figure 3F). We also transfect pNEAT1 into GES-1 cell and found NEAT1 overexpression could promote cell proliferation ( and ).
Figure 3

Influence of NEAT1 expression on GC cell growth.

Notes: (A) Cell proliferation rate in GC cells with pNEAT1 and pcNDA3.1 transfection. (B) Cell proliferation rate in GC cells with si-NEAT1 and NC-siR transfection. (C) Cell cycle distribution in GC cells with pNEAT1 and pcNDA3.1 transfection. (D) Cell cycle distribution in GC cells with si-NEAT1 and NC-siR transfection. (E) Colony formation ability in GC cells with pNEAT1 and pcNDA3.1 transfection. (F) Colony formation ability in GC cells with si-NEAT1 and NC-siR transfection. ***P<0.001; **P<0.01; ns not significant.

Abbreviations: NEAT1, nuclear paraspeckle assembly transcript 1; GC, gastric cancer; si-NEAT1, small interfering RNA against NEAT1; NC-siR, negative control small interfering RNA.

Influence of NEAT1 expression on GC cell growth. Notes: (A) Cell proliferation rate in GC cells with pNEAT1 and pcNDA3.1 transfection. (B) Cell proliferation rate in GC cells with si-NEAT1 and NC-siR transfection. (C) Cell cycle distribution in GC cells with pNEAT1 and pcNDA3.1 transfection. (D) Cell cycle distribution in GC cells with si-NEAT1 and NC-siR transfection. (E) Colony formation ability in GC cells with pNEAT1 and pcNDA3.1 transfection. (F) Colony formation ability in GC cells with si-NEAT1 and NC-siR transfection. ***P<0.001; **P<0.01; ns not significant. Abbreviations: NEAT1, nuclear paraspeckle assembly transcript 1; GC, gastric cancer; si-NEAT1, small interfering RNA against NEAT1; NC-siR, negative control small interfering RNA.

NEAT1 Could Interact with miR-365a-3p in GC

Bioinformatic analysis tool showed miR-365a-3p was a putative target of NEAT1 in GC (Figure 4A). RT-qPCR results indicated that miR-365a-3p expression level was upregulated by si-NEAT1 and downregulated by pNEAT1 in GC cells (Figure 4B and C). The results of luciferase activity reporter assay in Figure 4D indicated miR-365a-3p mimic decreased luciferase activity in GC cells transfected with NEAT1-wt. In addition, the analysis of miR-365a-3p in GC tissues at ENCORI showed it was decreased expression in GC tissues compared with normal tissues (Figure 4E).
Figure 4

NEAT1 interact with miR-365a-3p in GC.

Notes: (A) Binding model between NEAT1 and miR-365a-3p. (B) miR-365a-3p expression in GC cells with si-NEAT1 and NC-siR transfection. (C) miR-365a-3p expression in GC cells with pNEAT1 and pcNDA3.1 transfection. (D) Relative luciferase activity in GC cells with luciferase plasmids and miRNAs transfection. (E) miR-365a-3p expression in GC tissues and normal tissues. ***P<0.001.

Abbreviations: NEAT1, nuclear paraspeckle assembly transcript 1; GC, gastric cancer; si-NEAT1, small interfering RNA against NEAT1; NC-siR, negative control small interfering RNA; miR-365a-3p, microRNA-365a-3p; wt, wild-type; mt, mutant; NC-mimic, negative control mimic.

NEAT1 interact with miR-365a-3p in GC. Notes: (A) Binding model between NEAT1 and miR-365a-3p. (B) miR-365a-3p expression in GC cells with si-NEAT1 and NC-siR transfection. (C) miR-365a-3p expression in GC cells with pNEAT1 and pcNDA3.1 transfection. (D) Relative luciferase activity in GC cells with luciferase plasmids and miRNAs transfection. (E) miR-365a-3p expression in GC tissues and normal tissues. ***P<0.001. Abbreviations: NEAT1, nuclear paraspeckle assembly transcript 1; GC, gastric cancer; si-NEAT1, small interfering RNA against NEAT1; NC-siR, negative control small interfering RNA; miR-365a-3p, microRNA-365a-3p; wt, wild-type; mt, mutant; NC-mimic, negative control mimic.

miR-365a-3p Regulates ABCC4 Expression in GC

TargetScan showed miR-365a-3p has a binding site in 3ʹ-UTR of ABCC4 (Figure 5A). Results in Figure 5B revealed miR-365a-3p overexpression could decrease ABCC4 expression. We also found NEAT1 overexpression could increase, while NEAT1 knockdown could decrease ABCC4 expression in GC cells (Figure 5C and D). Luciferase activity assay showed luciferase activity in GC cells harboring ABCC4-wt was decreased by miR-365a-3p mimic (Figure 5E). Importantly, we showed ABCC4 was highly expressed in GC tissues and correlated with poorer overall survival of GC patients (Figure 5F and G).
Figure 5

miR-365a-3p interact with ABCC4 in GC.

Notes: (A) Binding model between ABCC4 and miR-365a-3p. (B) ABCC4 expression in GC cells with miR-365a-3p mimic and NC-mimic transfection. (C) ABCC4 expression in GC cells with pNEAT1 and pcNDA3.1 transfection. (D) ABCC4 expression in GC cells with si-NEAT1 and NC-siR transfection. (E) Relative luciferase activity in GC cells with luciferase plasmids and miRNAs transfection. (F) ABCC4 expression in GC tissues and normal tissues. (G) High ABCC4 expression was a predictor for poorer overall survival of cancer patients. ***P<0.001; **P<0.01.

Abbreviations: NEAT1, nuclear paraspeckle assembly transcript 1; GC, gastric cancer; si-NEAT1, small interfering RNA against NEAT1; NC-siR, negative control small interfering RNA; miR-365a-3p, microRNA-365a-3p; wt, wild-type; mt, mutant; NC-mimic, negative control mimic; ABCC4, ATP-binding cassette subfamily C member 4.

miR-365a-3p interact with ABCC4 in GC. Notes: (A) Binding model between ABCC4 and miR-365a-3p. (B) ABCC4 expression in GC cells with miR-365a-3p mimic and NC-mimic transfection. (C) ABCC4 expression in GC cells with pNEAT1 and pcNDA3.1 transfection. (D) ABCC4 expression in GC cells with si-NEAT1 and NC-siR transfection. (E) Relative luciferase activity in GC cells with luciferase plasmids and miRNAs transfection. (F) ABCC4 expression in GC tissues and normal tissues. (G) High ABCC4 expression was a predictor for poorer overall survival of cancer patients. ***P<0.001; **P<0.01. Abbreviations: NEAT1, nuclear paraspeckle assembly transcript 1; GC, gastric cancer; si-NEAT1, small interfering RNA against NEAT1; NC-siR, negative control small interfering RNA; miR-365a-3p, microRNA-365a-3p; wt, wild-type; mt, mutant; NC-mimic, negative control mimic; ABCC4, ATP-binding cassette subfamily C member 4.

NEAT1 Regulates GC Cell Behaviors via miR-365a-3p/ABCC4 Axis

At length, we explored whether NEAT1 regulates GC cell behaviors via miR-365a-3p/ABCC4 axis using rescue experiments. Results showed miR-365a-3p mimic or si-ABCC4 transfection decreased GC cell growth and invasion (Figure 6A–D). Rescue experiments showed miR-365a-3p mimic and si-ABCC4 could partially reverse the stimulation effects of pNEAT1 on GC cell growth and invasion to a different extent (Figure 6A–D).
Figure 6

NEAT1 regulates GC cell behaviors via targeting miR-365a-3p and ABCC4 axis.

Notes: (A) Effects of NEAT1 overexpression, miR-365a-3p overexpression, and ABCC4 knockdown on GC cell proliferation rate. (B) Effects of NEAT1 overexpression, miR-365a-3p overexpression, and ABCC4 knockdown on GC cell cycle progression. (C) Effects of NEAT1 overexpression, miR-365a-3p overexpression, and ABCC4 knockdown on GC cell colony formation. (D) Effects of NEAT1 overexpression, miR-365a-3p overexpression, and ABCC4 knockdown on GC cell invasion. ***P<0.001; **P<0.01; *P<0.05.

Abbreviations: NEAT1, nuclear paraspeckle assembly transcript 1; GC, gastric cancer; miR-365a-3p, microRNA-365a-3p; ABCC4, ATP-binding cassette subfamily C member 4; NC-mimic, negative control mimic; si-ABCC4, small interfering RNA against ABCC4; NC-siR, negative control small interfering RNA.

NEAT1 regulates GC cell behaviors via targeting miR-365a-3p and ABCC4 axis. Notes: (A) Effects of NEAT1 overexpression, miR-365a-3p overexpression, and ABCC4 knockdown on GC cell proliferation rate. (B) Effects of NEAT1 overexpression, miR-365a-3p overexpression, and ABCC4 knockdown on GC cell cycle progression. (C) Effects of NEAT1 overexpression, miR-365a-3p overexpression, and ABCC4 knockdown on GC cell colony formation. (D) Effects of NEAT1 overexpression, miR-365a-3p overexpression, and ABCC4 knockdown on GC cell invasion. ***P<0.001; **P<0.01; *P<0.05. Abbreviations: NEAT1, nuclear paraspeckle assembly transcript 1; GC, gastric cancer; miR-365a-3p, microRNA-365a-3p; ABCC4, ATP-binding cassette subfamily C member 4; NC-mimic, negative control mimic; si-ABCC4, small interfering RNA against ABCC4; NC-siR, negative control small interfering RNA.

Discussion

It has been widely recognized that lncRNAs play crucial roles in regulating carcinogenesis including GC.14,15 For instance, LINC00682 was found to decrease expression in GC cells, and its overexpression could upregulate LIM homeobox transcription factor 1α expression via serving as a sponge for miR-9 to thus result in the inhibition on GC cell growth, migration, and invasion.14 Another work indicated small nucleolar RNA host gene 7 (SNHG7) was highly expressed in GC and correlated with advanced tumor stages, poorer lymph-node metastasis, and overall survival.15 Moreover, SNHG7 was found could bind with miR-34a to stimulate GC migration and invasion via regulating Snail-EMT axis.15 However, more studies are needed to explore the biological roles of lncRNAs in GC. Previous studies indicated NEAT1 functions as an oncogenic lncRNA in cancers.7–9 In line with these studies, we showed NEAT1 was upregulated expression in both GC tissues and cells. In addition, we showed high NEAT1 level was an indicator of poorer overall survival of GC patients. In addition, gain and loss-of-function experiments indicated NEAT1 overexpression could promote GC cell proliferation, colony formation, cell cycle progression, and invasion. In addition, the knockdown of NEAT1 caused opposite effects on GC cell behaviors. The results showed NEAT1 functions as an oncogenic lncRNA in GC. There are some studies to indicate the roles of NEAT1 in regulating cancer viability and migration.10,16 Here, we also showed NEAT1 could regulate GC cell growth by regulating cell cycle distribution. Increasing evidence suggested lncRNA exerts its function mainly through functioning ceRNA for miRNA.17 Hence, we also supposed that NEAT1 acts as ceRNA to participate in GC development. Bioinformatic analysis tool and luciferase activity reporter assay showed NEAT1 could bind with miR-365a-3p. miR-365a-3p was previously revealed as a target for lncRNA ZEB1-AS1 and regulates the liver cancer cell proliferation.18 In this work, we found overexpression of miR-365a-3p could suppress GC cell growth and invasion, suggesting the tumor-suppressive role of miR-365a-3p. Furthermore, we also showed ABCC4 was a possible target of miR-365a-3p. ABCC4 is a member of MRP family of transporters and able to transport organic anionic compounds (both endogenous and xenobiotic) out of the cell.19 Besides that, it was found to have a close association with extracellular signaling pathways and drug resistance.19 Moreover, ABCC4 was widely expressed in human tissues.20 ABCC4 was found highly expressed in non-small cell lung cancer cells and its knockdown could suppress cancer cell growth.21 Here, we also showed ABCC4 expression was elevated in GC and correlated with poorer overall survival of cancer patients. Consider NEAT1 and ABCC4 can interact with miR-365a-3p, and hence, we speculated that NEAT1 may serve as sponge for miR-365a-3p to regulate ABCC4 expression in GC. Rescue experiment showed that overexpression of miR-365a-3p or knockdown of ABCC4 could partially reverse the effects of NEAT1 overexpression on GC cell events. However, we have to admit there is still a limitation in this work, which is we explored the expression of NEAT1, miR-365a-3p, and ABCC4 in GC tissues and normal tissues using the data from TCGA but we did not explore their expression levels in collected human tissues. Hence, in the future, we will recurit patients diagnosed with GC into our study to further investigate the roles of NEAT1 in GC.

Conclusion

In summary, we found NEAT1 was significantly upregulated in GC and correlated with poorer survival. Functional analyses indicated NEAT1 overexpression stimulates, and NEAT1 knockdown inhibits GC cell behaviors. Our study provided novel insights into the mechanisms underlying GC development.
  21 in total

Review 1.  Roles of competing endogenous RNAs in gastric cancer.

Authors:  Ye Hu; Haiying Tian; Jie Xu; Jing-Yuan Fang
Journal:  Brief Funct Genomics       Date:  2015-09-24       Impact factor: 4.241

2.  Gastrointestinal cancer: targeted therapies in gastric cancer-the dawn of a new era.

Authors:  Manish A Shah
Journal:  Nat Rev Clin Oncol       Date:  2013-12-03       Impact factor: 66.675

3.  SNHG7 accelerates cell migration and invasion through regulating miR-34a-Snail-EMT axis in gastric cancer.

Authors:  Yangmei Zhang; Yuan Yuan; Youwei Zhang; Long Cheng; Xichang Zhou; Kai Chen
Journal:  Cell Cycle       Date:  2019-12-08       Impact factor: 4.534

Review 4.  Gastric Cancer Etiology and Management in Asia and the West.

Authors:  Ashley E Russo; Vivian E Strong
Journal:  Annu Rev Med       Date:  2018-10-24       Impact factor: 13.739

5.  An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles.

Authors:  Christine M Clemson; John N Hutchinson; Sergio A Sara; Alexander W Ensminger; Archa H Fox; Andrew Chess; Jeanne B Lawrence
Journal:  Mol Cell       Date:  2009-02-12       Impact factor: 17.970

Review 6.  Cross-Kingdom Small RNAs Among Animals, Plants and Microbes.

Authors:  Jun Zeng; Vijai Kumar Gupta; Yueming Jiang; Bao Yang; Liang Gong; Hong Zhu
Journal:  Cells       Date:  2019-04-23       Impact factor: 6.600

7.  LncRNA ZEB1-AS1 reduces liver cancer cell proliferation by targeting miR-365a-3p.

Authors:  Mingfei Li; Hua Guan; Yuping Liu; Xianfeng Gan
Journal:  Exp Ther Med       Date:  2019-03-07       Impact factor: 2.447

8.  ABCC4 is required for cell proliferation and tumorigenesis in non-small cell lung cancer.

Authors:  Xiaoting Zhao; Yinan Guo; Wentao Yue; Lina Zhang; Meng Gu; Yue Wang
Journal:  Onco Targets Ther       Date:  2014-02-21       Impact factor: 4.147

9.  Functional Expression of Multidrug Resistance Protein 4 MRP4/ABCC4.

Authors:  David Hardy; Roslyn M Bill; Anass Jawhari; Alice J Rothnie
Journal:  SLAS Discov       Date:  2019-08-05       Impact factor: 3.341

10.  LINC00682 inhibits gastric cancer cell progression via targeting microRNA-9-LMX1A signaling axis.

Authors:  Xiaohong Zhang; Jian Li; Fan Li; Zhen Zhao; Li Feng
Journal:  Aging (Albany NY)       Date:  2019-12-11       Impact factor: 5.682

View more
  10 in total

1.  NEAT1 can be a diagnostic biomarker in the breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: integrated RNA targetome interaction and experimental expression analysis.

Authors:  Mansoureh Azadeh; Ali Salehzadeh; Kamran Ghaedi; Soheila Talesh Sasani
Journal:  Genes Environ       Date:  2022-05-17

2.  Downregulation of lncRNA NEAT1 Relieves Caerulein-Induced Cell Apoptosis and Inflammatory Injury in AR42J Cells Through Sponging miR-365a-3p in Acute Pancreatitis.

Authors:  Anjing Shao; Wei Hu; Chunxia Li; Yang Yang; Jianru Zhu
Journal:  Biochem Genet       Date:  2022-03-24       Impact factor: 1.890

Review 3.  Interplay between endoplasmic reticulum stress and non-coding RNAs in cancer.

Authors:  Tianming Zhao; Juan Du; Hui Zeng
Journal:  J Hematol Oncol       Date:  2020-12-02       Impact factor: 17.388

4.  LncRNA NEAT1 promotes nucleus pulposus cell matrix degradation through regulating Nrf2/ARE axis.

Authors:  Cheng Li; Xinjian Ma; Chenfei Ni; Jingyan Xu; Yinfei Xie; Junwei Kan; Xiaoli Wei
Journal:  Eur J Med Res       Date:  2021-01-21       Impact factor: 2.175

Review 5.  NEAT1 as a competing endogenous RNA in tumorigenesis of various cancers: Role, mechanism and therapeutic potential.

Authors:  Kun Li; Tongyue Yao; Yu Zhang; Wen Li; Ziqiang Wang
Journal:  Int J Biol Sci       Date:  2021-08-03       Impact factor: 6.580

6.  The inhibition of circular RNA circNOLC1 by propofol/STAT3 attenuates breast cancer stem cells function via miR-365a-3p/STAT3 signaling.

Authors:  Yi-Ping Liu; Jin-Yu Heng; Xin-Yu Zhao; En-You Li
Journal:  J Transl Med       Date:  2021-11-17       Impact factor: 5.531

7.  A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma.

Authors:  Sheng Yang; Jiahui Zhou; Zhihao Chen; Qingyang Sun; Dongsheng Zhang; Yifei Feng; Xiaowei Wang; Yueming Sun
Journal:  Front Oncol       Date:  2022-08-04       Impact factor: 5.738

Review 8.  Molecular Interactions of the Long Noncoding RNA NEAT1 in Cancer.

Authors:  Jingtao Gu; Bo Zhang; Rui An; Weikun Qian; Liang Han; Wanxing Duan; Zheng Wang; Qingyong Ma
Journal:  Cancers (Basel)       Date:  2022-08-19       Impact factor: 6.575

9.  A Novel miRNA-Based Model Can Predict the Prognosis of Clear Cell Renal Cell Carcinoma.

Authors:  Jiyue Wu; Feilong Zhang; Jiandong Zhang; Zejia Sun; Changzhen Hao; Huawei Cao; Wei Wang
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

10.  LncRNA Nuclear-Enriched Abundant Transcript 1 Regulates Atrial Fibrosis via the miR-320/NPAS2 Axis in Atrial Fibrillation.

Authors:  Huangdong Dai; Naishi Zhao; Hua Liu; Yue Zheng; Liang Zhao
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.